Stay updated on Efruxifermin in NASH Subjects Clinical Trial
Sign up to get notified when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.

Latest updates to the Efruxifermin in NASH Subjects Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check11 days agoChange DetectedThe record describes a completed Phase 2 study evaluating efruxifermin against placebo in people with NASH, with details on eligibility, study locations, and measured outcomes. It also includes trial history, related publications, and study documents.SummaryDifference62%

- Check19 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check33 days agoChange DetectedA notice about NIH’s terminology transition was added above the unavailable study record, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe 403 error page footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check61 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error page, replacing the usual study details. The page now displays a 403 message and a generic site footer instead of the study content.SummaryDifference18%

Stay in the know with updates to Efruxifermin in NASH Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.